Search Results - "Sanh, Alan"

Next-generation nanomedicines and nanosimilars: EU regulators' initiatives relating to the development and evaluation of nanomedicines by Ehmann, Falk, Sakai-Kato, Kumiko, Duncan, Ruth, Hernán Pérez de la Ossa, Dolores, Pita, Ruben, Vidal, Jean-Marc, Kohli, Ashish, Tothfalusi, Laszlo, Sanh, Alan, Tinton, Sandrine, Robert, Jean-Louis, Silva Lima, Beatriz, Amati, Marisa Papaluca

“…Over the last three decades many first-generation nanomedicines have successfully entered routine clinical use and it is now important for medicines regulatory…”
Get more information

Determining recommended acceptable intake limits for N-nitrosamine impurities in pharmaceuticals: Development and application of the Carcinogenic Potency Categorization Approach (CPCA) by Kruhlak, Naomi L., Schmidt, Marianne, Froetschl, Roland, Graber, Stefan, Haas, Bodo, Horne, Irene, Horne, Stephen, King, Sruthi T., Koval, Iryna A., Kumaran, Govindaraj, Langenkamp, Anja, McGovern, Timothy J., Peryea, Tyler, Sanh, Alan, Siqueira Ferreira, Aline, van Aerts, Leon, Vespa, Alisa, Whomsley, Rhys

“…N-Nitrosamine impurities, including nitrosamine drug substance-related impurities (NDSRIs), have challenged pharmaceutical industry and regulators alike and…”
Get full text

Peptide-rna recognition: investigation of non-covalent interactions using esi-mass spectrometry and proton nmr spectroscopy by Sanh, Alan Dominique

“…Non-covalent interactions between amino acids, peptides and proteins with RNA play significant roles in many biological systems. Therefore, the aim of this…”
Get full text